Who is sponsoring NCT04084652?

NCT04084652 is sponsored by University of Exeter.

What drugs are being tested in NCT04084652?

Interventions in NCT04084652: Mycoprotein ingestion.

What condition does NCT04084652 study?

NCT04084652 studies Anabolic Response to Mycoprotein and Micronutrient Ingeston.

Is NCT04084652 still recruiting?

NCT04084652 is currently completed. Last updated 27 May 2022.

Last reviewed 2022-05-27 · How we verify

NCT04084652: PIMP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mycoprotein and Muscle Protein Synthetic Response

Completed NA Last updated 27 May 2022

What this trial tests

NA trial testing Mycoprotein ingestion in Anabolic Response to Mycoprotein and Micronutrient Ingeston in 24 participants. Completed in 11 December 2019.

Timeline

15 April 2019

Primary endpoint
11 December 2019

11 December 2019

Quick facts

Lead sponsor	University of Exeter
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	basic science
Enrollment	24
Start date	15 April 2019
Primary completion	11 December 2019
Estimated completion	11 December 2019
Sites	1 location across United Kingdom

Drugs / interventions tested

Mycoprotein ingestion

Conditions studied

Anabolic Response to Mycoprotein and Micronutrient Ingeston — all drugs for Anabolic Response to Mycoprotein and Micronutrient Ingeston →

Sponsor

University of Exeter

Who can join

Adults 18 to 40, male only, with Anabolic Response to Mycoprotein and Micronutrient Ingeston. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dietary protein is vital for the preservation of health and optimal adaptation to training. However, traditional animal proteins come with a number of economic, environmental, and ethical issues. Accordingly, there is a need to develop an understanding of the utility of more sustainable non-animal derived dietary proteins to support our nutrition. Mycoprotein, produced by Quorn Foods™, has recently been shown to stimulate a greater anabolic response within skeletal muscle compared with milk protein, suggesting its utility within sports nutrition. However, it is unclear what accounted for the greater anabolic response of mycoprotein. One explanation could be the non-protein nutrients contained within mycoprotein (e.g. fibre, carbohydrate, fat or micronutrients). Therefore, the present study will compare the muscle anabolic response between mycoprotein (MYC) as a whole food and the protein isolated from mycoprotein (PIM).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mycoprotein ingestion within or without its wholefood matrix results in equivalent stimulation of myofibrillar protein synthesis rates in resting and exercised muscle of young men.
West S, Monteyne AJ, Whelehan G, Abdelrahman DR, et al · · 2023 · cited 24× · PMID 36172885 · DOI 10.1017/s0007114522003087

Verify or expand the search:

Other University of Exeter trials

Trials by the same sponsor.

NCT07457437 — Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment · NA · recruiting
NCT06478121 — Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE) · recruiting
NCT06965699 — The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults · NA · recruiting
NCT06846294 — Obesity Prevention in Children and Young People Treated for Acute Lymphoblastic Leukaemia with ALLTogether · NA · not yet recruiting
NCT06852547 — The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adu · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04084652 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Exeter
Last refreshed: 27 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04084652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing